Hyperviscosity in Polycythemia Vera and Other Red Cell Abnormalities

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 5, 2003, Pages 451-458

  Kwaan, Hau C ^a,b   Wang, Jun ^b  

^a Northwestern University ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hyperviscosity; Polycythemia vera; Red cell aggregation; Rheology; Thrombosis

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; BUSULFAN; CHLORAMBUCIL; HYDROXYUREA;

BLEEDING TENDENCY; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CAPILLARY FLOW; CELL DAMAGE; CELL INTERACTION; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ERYTHROCYTE DISORDER; FIBRINOLYSIS; FLOW KINETICS; HEART INFARCTION; HEMATOCRIT; HUMAN; HYPERVISCOSITY SYNDROME; LEUKOCYTE ACTIVATION; LUNG EMBOLISM; MYELOFIBROSIS; NEUROLOGIC DISEASE; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTOSIS; THROMBOGENESIS; THROMBOSIS;

BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTES, ABNORMAL; HEMATOCRIT; HUMANS; POLYCYTHEMIA VERA;

EID: 0242298638     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44552     Document Type: Review

References (52)

1. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood 2002;100:4272-4290
2. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995;123:656-664
3. Berk PD, Goldberg JD, Donovan PB, et al. Therapeutic recommendations in polycythemia vera based on polycythemia vera study protocols. Semin Hematol 1986;23:132-143
4. Wasserman LR, Balcerzak SP, Berk PD, et al. Influence of therapy on causes of death in polycythemia vera. Trans Assoc Am Phys 1981;94:30-38
5. Donovan PB, Kaplan ME, Goldberg JD, et al. Treatment of polycythemia vera with hydroxyurea. Am J Hematol 1984; 17:329-334
6. Tatarsky I, Shron R. Management of polycythemia vera with hydroxyurea. Semin Hematol 1997;34:24-28
7. Chievitz E, Thiede E. Complications and causes of death in polycythemia vera. Acta Med Scand 1962;172:513-523
8. Begg TB, Hearns JB. Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins. Clin Sci 1966;31:87-93
9. Jensen MK, de Nully BP, Lund BV, Nielsen OJ, Hasselbalch HC. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders. Br J Haematol 2000;110:116-124
10. Turitto V, Weiss H. Red blood cells: their dual role in thrombus formation. Science 1976;207:541-543
11. Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999;33:821-828
12. Kornberg A, Rahimi-Levene N, Yona R, Mor A, Rachmilewitz EA. Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol 1997;56:5-11
13. Posan E, Ujj G, Kiss A, et al. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia. Thromb Res 1998;90:51-56
14. Lamparter S, Schuermann M, Heidtmann H-H. APC resistance as an additional thrombotic risk factor in a patient suffering from polycythemia vera and recurrent thrombosis. Ann Hematol 1997;74:49-50
15. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000; 96:4261-4266
16. Kwaan HC, Suwanwela N. Inhibitors of fibrinolysis in platelet on polycythemia vera and thrombocytosis. Br J Haematol 1971;21:313-322
17. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003;29:435-450
18. Wells RE, Merrill EW. Influence of flow properties of blood upon viscosity-hematocrit relationships. J Clin Invest 1962; 41:1591-1598
19. Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood 2002;99:1144-1149
20. Pearson TC, Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythemia. Lancet 1978;2:1219-1221
21. Pearson TC. Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera. Semin Thromb Hemost 1997;23:433-439
22. Brown G, Giffin HZ. Studies of capillaries and blood volume in polycythemia vera. Am J Med Sci 1923;166:489-502
23. Kwaan HC, Harding F, Astrup T. Platelet behavior in small blood vessels in vivo. Thrombosis et Diathesis Haemorrhagica 1967;18:207-220
24. Barabas AP, Offen DN, Meinhard EA. The arterial complications of polycythemia vera. Br J Surg 1973;60:183-187
25. Pearson TC, Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet 1978;2:1218-1222
26. Taylor GW, Calo AR. Atherosclerosis of arteries of the lower limb. BMJ 1962;1:507-510
27. Murray JF, Escobar E. Circulatory effects of blood viscosity: comparison of methemoglobinemia and anemia. J Appl Physiol 1968;25:594-599
28. Massik J, Tang YL, Hudak ML, et al. Effect of hematocrit on cerebral blood flow with induced polycythemia. J Appl Physiol 1987;62:1090-1096
29. Pearson TC. Rheology of the absolute polycythemias. Baillieres Clin Haematol 1987;1:637-664
30. Brown MM, Wade JP, Marshall J. Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 1985;108:81-93
31. Mitchell MC, Biotnott JK, Kaufman S, Cameron JL, Maddrey WC. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine 1982;61:199-218
32. Dintenfass L. Experiment on "Discovery" STS 51-C. Aggregation of red cells and thrombocytes in heart disease, hyperlipidemia and other conditions. Adv Space Res 1959;9:65-69
33. van Haeringen NJ, Oosterhuis JA, Terpstre J, Glasius E. Erythrocyte aggregation in relation to diabetic retinopathy. Diabetologia 1973;9:20-24
34. Schmid-Schönbein H, Volger E. Red-cell aggregation and red-cell deformability in diabetes. Diabetes 1976;25(Suppl 2): 897-902
35. Le Devehat C, Vimcux M, Bondoux G, Khodabandchlou T. Red blood cell aggregation in diabetes mellitus. Int Angiol 1990;9:11-15
36. Ziegler O, Guerci B, Muller S, et al. Increased erythrocyte aggregation in insulin dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis. Metabolism 1994;43:1182-1186
37. Dintenfass L, Somer T. On the aggregation of red cells in Waldenström's macroglobulinaemia and multiple myeloma. Microvasc Res 1975;9:279-286
38. Razavian SM, Atger V, Giral P, et al. Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men: PCVMETRA group. Arterioscler Thromb Vasc Biol 1994;14:361-366
39. Vaya A, Martinez M, Carmena R, Aznar J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res 1993;72:119-126
40. Tranquilli AL, Garzetti GG, De Tommaso G, et al. Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normal. Am J Obstet Gynecol 1992;167: 942-945
41. Bohler T, Linderkamp O, Leo A, Wingen AM, Scharer K. Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome. Clin Nephrol 1992;38:119-124
42. Razavian SM, Del Pino M, Simon A, Levenson J. Increase in erythrocyte disaggregation shear stress in hypertension. Hypertension 1992;20:247-252
43. Williams L, Domen RE. Vancomycin-induced red cell aggregation. Transfusion 1989;29:23-26
44. Kallio T, Alanen A, Kormano M. The effect of radiographic contrast media on ultrasonically detectable red blood cell aggregation in vitro. Invest Radiol 1989;24:789-793
45. Kwaan HC, Levin M, Sakurai S, et al. Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia. J Vasc Surg 1997;26:1061-1068
46. Chen S, Eldor A, Barshtein G, et al. Enhanced aggregability of red cells of β-thalassemia major patients. Am J Physiol 1996;270:H1951-H1956
47. Obiefima PC. Rouleaux formation in sickle cell traits. J Trop Med 1991;94:42-44
48. Palek J, Lux SE. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin Hematol 1983; 20:189-224
49. Wright IG. An electron microscopic study of intravascular agglutination in the cerebral cortex due to Babesia argentina infection. Int J Parasitol 1972;2:209-215
50. Miller LH, Usami S, Chien S. Alteration in the rheologic properties of Plasmodium knowlesi-infected red cells: a possible mechanism for capillary obstruction. J Clin Invest 1971; 50:1451-1455
51. Chien S, Cooper GW Jr, Jan KM, et al. N-acetylneuraminic acid deficiency in erythrocyte membranes: biophysical and biochemical correlates. Blood 1974;43:445-460
52. Zarkovic M, Kwaan, HC. Correction of hyperviscosity by apheresis. Semin Thromb Hemost 2003;29:535-542